Delivery Systems for Gene-based Vaccines

Molecular Medicine

Volumn 6, Issue 9, 2000, Pages 723-732

  Dubensky, Thomas W ^a   Liu, Margaret A ^a   Ulmer, Jeffrey B ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Alphavirus Replicon; Alphavirus Vectors; Gene based Vaccines; Replicon Particles; Venezuelan Equine Encephalitis Virus

Indexed keywords

DNA VACCINE;

DRUG DELIVERY SYSTEM; HUMAN; METHODOLOGY; REVIEW; VACCINATION;

DRUG DELIVERY SYSTEMS; HUMANS; VACCINATION; VACCINES, DNA;

MLCS; MLOWN;

EID: 0034277811     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03402189     Document Type: Review

References (69)

1. T.W. Dubensky B.A. Campbell L.P. Villarreal Direct transfection of viral and plasmid DNA into the liver or spleen of mice Proc. Natl. Acad. Sci. U.S.A. 1984 81 7529 7533 1:CAS:528:DyaL2MXntlGjtw%3D%3D 10.1073/pnas.81.23.7529
2. N. Benvenisty L. Reshef Direct introduction of genes into rats and expression of the genes Proc. Natl. Acad. Sci. U.S.A. 1986 83 9551 9555 1:CAS:528:DyaL2sXnvFGrtg%3D%3D 10.1073/pnas.83.24.9551
3. J.A. Wolff R.W. Malone P. Williams et al. Direct gene transfer into mouse muscle in vivo Science 1990 247 1465 1468 1:CAS:528:DyaK3cXhslemsbg%3D 10.1126/science.1690918
4. D.C. Tang M. De Vit S.A. Johnston Genetic immunization is a simple method for eliciting an immune response Nature 1992 356 152 154 1:CAS:528:DyaK38XhslWkt7w%3D 10.1038/356152a0
5. J.B. Ulmer J.J. Donnelly S.E. Parker et al. Heterologous protection against influenza by injection of DNA encoding a viral protein Science 1993 259 1745 1749 1:CAS:528:DyaK3sXitFSqtrk%3D 10.1126/science.8456302
6. J.J. Donnelly J.B. Ulmer J.W. Shiver M.A. Liu DNA vaccines Annu. Rev. Immunol. 1997 15 617 648 1:CAS:528:DyaK2sXisVCmtLs%3D 10.1146/annurev.immunol.15.1.617
7. J. Haas E.C. Park B. Seed Codon usage limitation in the expression of HIV-1 envelope glycoprotein Curr. Biol. 1996 6 315 324 1:CAS:528:DyaK28XhvFymurc%3D 10.1016/S0960-9822(02)00482-7
8. S. Andre B. Seed J. Eberle W. Schraut A. Bultmann J. Haas Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage J. Virol. 1998 72 1497 1503 1:CAS:528:DyaK1cXlt1Kmuw%3D%3D 9445053 124631
9. M.C. Chen B. Doe M. Schaefer et al. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene J. Virol. 2000 74 2628 2635 10.1128/JVI.74.6.2628-2635.2000
10. M. Uchijima A. Yoshida T. Nagata Y. Koide Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium J. Immunol. 1998 161 5594 5599 1:CAS:528:DyaK1cXnsVOqtrY%3D 9820537
11. J. Hartikka M. Sawdey F. Cornefert-Jensen et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle Hum. Gene. Ther. 1996 7 1205 1217 1:CAS:528:DyaK28XksF2rsbg%3D 10.1089/hum.1996.7.10-1205
12. L. Qin Y. Ding D.R. Pahud E. Chang M.J. Imperiale J.S. Bromberg Promoter attenuation in gene therapy: interferon-γ and tumor necrosis factor-α inhibit transgene expression Hum. Gene Ther. 1997 8 2019 2029 1:CAS:528:DyaK2sXnslSktLk%3D 10.1089/hum.1997.8.17-2019
13. T. Jakob P.S. Walker A.M. Krieg M.C. Udey J.C. Vogel Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA J. Immunol. 1998 161 3042 3049 1:CAS:528:DyaK1cXmtVGmsr8%3D 9743369
14. J.S. Boyle C. Koniaras A.M. Lew Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization Int. Immunol. 1997 9 1897 1906 1:CAS:528:DyaK1cXktVWjtA%3D%3D 10.1093/intimm/9.12.1897
15. S.L. Baldwin C.D. D’Souza I.M. Orme et al. Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A Tuber. Lung. Dis. 1999 79 251 259 1:STN:280:DC%2BD3c7lslersQ%3D%3D 10.1054/tuld.1998.0196
16. W.L. McClements M.E. Armstrong R.D. Keys M.A. Liu Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease Proc. Natl. Acad. Sci. U.S.A. 1996 93 11414 11420 1:CAS:528:DyaK28XmtlagsLg%3D 10.1073/pnas.93.21.11414
17. T. Tobery R. Siliciano Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization J. Exp. Med. 1997 185 909 920 1:CAS:528:DyaK2sXhsFKnsL4%3D 10.1084/jem.185.5.909
18. F. Rodriguez J. Zhang J. Whitton DNA immunization: ubiquitination of a viral protein enhances cytotoxic T lymphocyte induction and antiviral protection but abrogates antibody induction J. Virol. 1997 71 8497 8503 1:CAS:528:DyaK2sXmvV2hsLo%3D 9343207 192313
19. T.M. Fu L. Guan A. Friedman J.B. Ulmer M.A. Liu J.J. Donnelly Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens Vaccine 1998 16 1711 1717 1:CAS:528:DyaK1cXmsVCitbs%3D 10.1016/S0264-410X(98)00134-0
20. O. Vidalin E. Tanaka U. Spengler C. Trepo G. Inchauspe Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination DNA Cell Biol. 1999 18 611 621 1:CAS:528:DyaK1MXlt1Kitbk%3D 10.1089/104454999315024
21. J.S. Boyle J.L. Brady A.M. Lew Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction Nature 1998 392 408 411 1:CAS:528:DyaK1cXitlShurs%3D 10.1038/32932
22. A. Biragyn K. Tani M.C. Grimm S. Weeks L.W. Kwak Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity Nat. Biotechnol. 1999 17 253 258 1:CAS:528:DyaK1MXhs1Chsbo%3D 10.1038/6995 [see comments]
23. S. Sasaki T. Tsuji Y. Asakura J. Fukushima K. Okuda The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants Anticancer Res. 1998 18 3907 3915 1:CAS:528:DyaK1MXjtVarsg%3D%3D 9854503
24. M.G. Agadjanyan J.J. Kim N. Trivedi et al. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo J. Immunol. 1999 162 3417 3427 1:CAS:528:DyaK1MXhvV2rurk%3D 10092797
25. J.B. Ulmer C.M. DeWitt M. Chastain et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants Vaccine 1999 18 18 28 1:CAS:528:DyaK1MXmsFOit70%3D 10.1016/S0264-410X(99)00151-6
26. D. Klinman G. Yamshchikov Y. Ishigatsubo Contribution of CpG Motifs to the Immunogenicity of DNA Vaccines J. Immunol. 1997 158 3635 3639 1:CAS:528:DyaK2sXisFCitb4%3D 9103425
27. Y. Sato M. Roman H. Tighe et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization Science 1996 273 352 354 1:CAS:528:DyaK28Xktl2is74%3D 10.1126/science.273.5273.352
28. A.M. Krieg T. Wu R. Weeratna et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs Proc. Natl. Acad. Sci U.S.A. 1998 95 12631 12636 1:CAS:528:DyaK1cXmsl2qur8%3D 10.1073/pnas.95.21.12631
29. R. Weeratna M.C. Brazolot A.M. Krieg H.L. Davis Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides Antisense Nucleic Acid Drug Dev. 1998 8 351 356 1:CAS:528:DyaK1cXlvFGmtLw%3D 10.1089/oli.1.1998.8.351
30. W.W. Nichols B.J. Ledwith S.V. Manam P.J. Troilo Potential DNA vaccine integration into host cell genome Ann. NY Acad. Sci. 1995 772 30 39 1:CAS:528:DyaK28Xit1Gmt7s%3D 10.1111/j.1749-6632.1995.tb44729.x
31. M.A. Chattergoon T.M. Robinson J.D. Boyer D.B. Weiner Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigenpresenting cells J. Immunol. 1998 160 5707 5718 1:CAS:528:DyaK1cXjvVWkurY%3D 9637479
32. O. Akbari N. Panjwani S. Garcia R. Tascon D. Lowrie B. Stockinger DNA vaccination: transfection and activation of dendritic cells as key events for immunity J. Exp. Med. 1999 189 169 178 1:CAS:528:DyaK1MXjs1OnsQ%3D%3D 10.1084/jem.189.1.169
33. A. Bouloc P. Walker J.C. Grivel J.C. Vogel S.I. Katz Immunization through dermal delivery of protein-encoding DNA: a role for migratory dendritic cells Eur. J. Immunol. 1999 29 446 454 1:CAS:528:DyaK1MXhsVanu7o%3D 10.1002/(SICI)1521-4141(199902)29:02<446::AID-IMMU446>3.0.CO;2-A
34. I. Mathiesen Electropermeabilization of skeletal muscle enhances gene transfer in vivo Gene Ther. 1999 6 508 514 1:CAS:528:DyaK1MXit1Omu7k%3D 10.1038/sj.gt.3300847
35. G. Widera M. Austin D. Rabussay et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo J. Immunol. 2000 164 4635 4640 1:CAS:528:DC%2BD3cXivFWmtLg%3D 10.4049/jimmunol.164.9.4635
36. A.Y. Huang P. Golumbek M. Ahmadzadeh E. Jaffee D. Pardoll H. Levitsky Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens Science 1994 264 961 965 1:CAS:528:DyaK2cXjt1SqtbY%3D 10.1126/science.7513904
37. J.B. Ulmer R.R. Deck C.M. DeWitt J.I. Donnhly M.A. Liu Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells Immunology 1996 89 59 67 1:CAS:528:DyaK28XlsVKrsLc%3D 10.1046/j.1365-2567.1996.d01-718.x
38. T.M. Fu J.B. Ulmer M.J. Caulfield et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes Mol. Med. 1997 3 362 371 1:CAS:528:DyaK2sXltFCntro%3D 10.1007/BF03401683
39. L. Timares A. Takashima S.A. Johnston Quantitative analysis of the immunopotency of genetically transfected dendritic cells Proc. Natl. Acad. Sci. U.S.A. 1998 95 13147 13152 1:CAS:528:DyaK1cXntFWku7c%3D 10.1073/pnas.95.22.13147
40. D. Loirat Z. Li M. Mancini P. Tiollais D. Paulin M.L. Michel Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses Virology 1999 260 74 83 1:CAS:528:DyaK1MXktlyns7Y%3D 10.1006/viro.1999.9795
41. E. Manickan S. Kanangat R.J. Rouse Z. Yu B.T. Rouse Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells J Leukocyte Biol. 1997 61 125 132 1:CAS:528:DyaK2sXhtVOlurY%3D 10.1002/jlb.61.2.125
42. S. Casares K. Inaba T.D. Brumeanu R.M. Steinman C.A. Bona Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope J. Exp. Med. 1997 186 1481 1486 1:CAS:528:DyaK2sXntFertb4%3D 10.1084/jem.186.9.1481
43. M. Singh M. Briones G.S. Ott D.T. O’Hagan Cationic microparticles: a potent delivery system for DNA vaccines Proc. Natl. Acad. Sci. U.S.A. 2000 97 811 816 1:CAS:528:DC%2BD3cXot1antQ%3D%3D 10.1073/pnas.97.2.811
44. T.W. Dubensky J.M. Polo D.J. Jolly N.S. Templeton D.D. Lasic Alphavirus-based vectors for vaccine and gene therapy applications GeneTherapy: Therapeutic Mechanisms and Strategies 2000 New York Marcel Dekker, Inc. 103 109
45. S. Schlesinger T.W. Dubensky Alphavirus vectors for gene expression and vaccines Curr. Opin. Biotechnol. 1999 10 434 439 1:CAS:528:DyaK1MXmslGisLo%3D 10.1016/S0958-1669(99)00006-3
46. J.H. Strauss E.G. Strauss The alphaviruses: gene expression, replication, and evolution Microbiol. Rev. 1994 58 491 562 1:CAS:528:DyaK2cXmsFSlu7s%3D 7968923 372977 [published erratum appears in Microbiol. Rev. 1994, 58:806]
47. D.A. Driver J.M. Polo B.A. Belli et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer J. Virol. 1996 70 508 519 8523564 189839
48. P. Berglund C. Smerdou M.N. Fleeton I. Tubulekas P. Liljestrom Enhancing immune responses using suicidal DNA vaccines Nat. Biotechnol. 1998 16 562 565 1:CAS:528:DyaK1cXjs1Glurk%3D 10.1038/nbt0698-562 [see comments]
49. H. Herweijer J.S. Latendresse P. Williams et al. A plasmid-based self-amplifying Sindbis virus vector Hum. Gene Ther. 1995 6 1161 1167 1:CAS:528:DyaK2MXot1yisbs%3D 10.1089/hum.1995.6.9-1161
50. P.J. Bredenbeek I. Frolov C.M. Rice S. Schlesinger Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs J. Virol. 1993 67 6439 6446 1:CAS:528:DyaK2cXhslWk 8411346 238079
51. P. Pushko M. Parker G.V. Ludwig N.L. Davis R.E. Johnston J.F. Smith Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo Virology 1997 239 389 401 1:CAS:528:DyaK1cXjt1yisA%3D%3D 10.1006/viro.1997.8878
52. J.M. Polo B.A. Belli D.A. Driver et al. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors Proc. Natl. Acad. Sci. U.S.A. 1999 96 4598 4603 1:CAS:528:DyaK1MXjs1ylsbY%3D 10.1073/pnas.96.8.4598
53. C. Smerdou P. Liljestrom Two-helper RNA system for production of recombinant Semliki Forest virus particles J. Virol. 1999 73 1092 1098 1:CAS:528:DyaK1MXmtlWqsw%3D%3D 9882310 103929
54. M.J. Hariharan D.A. Driver K. Townsend et al. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector J. Virol. 1998 72 950 958 1:CAS:528:DyaK1cXlt1Cruw%3D%3D 9444987 124565
55. W.W. Leitner H. Ying D.A. Driver T.W. Dubensky N.P. Restifo Enhancement of tumor-specific immune response with plasmid DNA replicon vectors Cancer Res. 2000 60 51 55 1:CAS:528:DC%2BD3cXnt1ahtA%3D%3D 10646851 2249696
56. M. Cella M. Salio Y. Sakakibara H. Langen I. Julkunen A. Lanzavecchia Maturation, activation, and protection of dendritic cells induced by double-stranded RNA J. Exp. Med. 1999 189 821 829 1:CAS:528:DyaK1MXhsF2ju70%3D 10.1084/jem.189.5.821
57. M.L. Albert B. Sauter N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 1998 392 86 89 1:CAS:528:DyaK1cXhvVOntrw%3D 10.1038/32183
58. X. Zhou P. Berglund H. Zhao P. Liljestrom M. Jondal Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus Proc. Natl. Acad. Sci. U.S.A. 1995 92 3009 3013 1:CAS:528:DyaK2MXksl2rurs%3D 10.1073/pnas.92.7.3009
59. N.L. Davis K.W. Brown R.E. Johnston A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge J. Virol. 1996 70 3781 3787 1:CAS:528:DyaK28XivF2msbs%3D 8648713 190254
60. P. Berglund M.N. Fleeton C. Smerdou P. Liljestrom Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice Vaccine 1999 17 497 507 1:STN:280:DyaK1M7ntFOgtQ%3D%3D 10.1016/S0264-410X(98)00224-2
61. M. Hevey D. Negley P. Pushko J. Smith A. Schmaljohn Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates Virology 1998 251 28 37 1:CAS:528:DyaK1cXnsFelt7k%3D 10.1006/viro.1998.9367
62. P. Berglund M. Quesada-Rolander P. Putkonen G. Biberfeld R. Thorstensson P. Liljestrom Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus AIDS Res. Hum. Retroviruses 1997 13 1487 1495 1:CAS:528:DyaK2sXnvFahtbY%3D 10.1089/aid.1997.13.1487
63. S.P. Mossman F. Bex P. Berglund et al. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine J. Virol. 1996 70 1953 1960 1:CAS:528:DyaK28XpvFartQ%3D%3D 8627721 190024
64. N.L. Davis I.J. Caley K.W. Brown et al. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles J. Virol. 2000 74 371 378 1:CAS:528:DC%2BD3cXkvVKl 10.1128/JVI.74.1.371-378.2000
65. G.H. MacDonald R.E. Johnston Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis J. Virol. 2000 74 914 922 1:CAS:528:DC%2BD3cXkt1Ckug%3D%3D 10.1128/JVI.74.2.914-922.2000
66. P. Borrow C.F. Evans M.B. Oldstone Virus-induced immunosuppression: immune systemmediated destruction of virus-infected dendritic cells results in generalized immune suppression J. Virol. 1995 69 1059 1070 1:CAS:528:DyaK2MXjtlGqt7w%3D 7815484 188677
67. M.T. Tuittila M.G. Santagati M. Roytta J.A. Maatta A.E. Hinkkanen Replicase complex genes of Semliki Forest virus confer lethal neurovirulence J. Virol. 2000 74 4579 4589 1:CAS:528:DC%2BD3cXivFygurs%3D 10.1128/JVI.74.10.4579-4589.2000
68. T. Hanke R.V. Samuel T.J. Blanchard et al. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen J. Virol. 1999 73 7524 7532 1:CAS:528:DyaK1MXltlKht7k%3D 10438842 104279
69. S.J. Kent A. Zhao S.J. Best J.D. Chandler D.B. Boyle I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J. Virol. 1998 72 10180 10188 1:CAS:528:DyaK1cXnsF2nsL4%3D 9811759 110562